 |
Our team |
 |
|
| |
The people at Zephyr are open minded and flexible, but above all, they are highly motivating in making the microarray platform accessible for broad range of application.
Management
Ely Morag, PhD,
Chief Scientist and Head of R&D
Dr. Morag is a expert in the field of biochemistry and biotechnology, specializing in affinity chromatography and cellulose-degrading enzymes. He was formerly project leader in ProChon Biotech, an Israeli company involved in discovery and development of innovative growth factor-based therapies, and a director of Shiloov Biotechnology, another Israeli company involved in rapid analysis of blood-transmitted viral diseases. Dr. Morag was a co-founder and consultant at Yamit Biotechnology Ltd, a company developing natural treatment for mastitis, which is the most common disease afflicting diary herds. He obtained a Ph.D from the Department of Molecular Microbiology and Biotechnology of Tel-Aviv University.
E-mail: Ely@zephyr.co.il
Scientific board
Zephyr's Scientific Advisory Board consists of two well-recognized scientists in the fields of affinity-based chromatography, avidin-biotin technology and cellulase-cellulose interactions. The scientific advisory board provides Zephyr new and innovative scientific directions with respect to new applications for the Zephyrin molecule and its related technologies.
Prof Meir Wilchek
Chairman of the Scientific Advisory Board
Meir Wilchek is a professor at the Weizmann Institute of Science in Rehovot. He is an opinion leader in the field of biorecognition or "affinity" phenomenon, and its application for various purposes. He is a key scientist for initiating and developing this field, and was responsible for the development of the avidin-biotin system as a general tool in the biological sciences. He is the recipient of numerous awards, including the Israel Prize, the Wolf Prize, the Rothschild Prize, the Pierce Award, the Sarstedt Prize, the International Distinguished Clinical Chemist Award of the International Federation of Clinical Chemistry and the Anfinsen Award of the Protein Society. He is a member of the Israel Academy of Sciences and Humanities, a Foreign Associate Member of the Institute of Medicine of the National Academy of Science, USA. He has been awarded honorary doctorates in Universities both in Israel (Bar Ilan and Ben-Gurion University of the Negev) and abroad (University of Waterloo, Canada, and University of Jyväskyla, Finland).
Prof Ed Bayer
Director and Scientific Advisor
Edward A. Bayer is an associate professor in the Department of Biological Chemistry at the Weizmann Institute of Science, Rehovot, Israel. Since the early 1970s, he has been involved in the development of the avidin-biotin system as a general tool in the biological sciences. He was co-discoverer of the cellulosome concept in the early 1980s. In 1999, he was organizer and Co-chair of the first Gordon Research Conference on "Cellulases and Cellulosomes", and he served as Chairman of the same conference in 2001. During his career, he has authored over 230 articles and reviews in both fields and is editor of the review journal, Biotechnology Advances. Professor Bayer was elected as a Fellow of the American Academy of Microbiology and received the Sarstedt Prize for application of the avidin-biotin system in clinical medicine.
 | |
 |
|